Krisztina Turi Nemenyi

Krisztina Turi Nemenyi, Ph.D has held various leadership positions in the regulatory affairs and quality field throughout their career. Krisztina currently serves as the SVP of Regulatory Affairs and Quality at Cyteir Therapeutics, where they are responsible for the establishment of successful regulatory strategies for the development and approval of the company's products. Prior to this, they worked at Takeda in multiple roles, including Vice President of Global Program Lead Oncology, Vice President of Global Regulatory Affairs Oncology, and Vice President of Regulatory Affairs for Emerging Markets and Marketed Products. Before joining Takeda, they held positions at Bristol-Myers Squibb, Bayer HealthCare, Baxter Healthcare, and American Pharmaceutical, where they gained extensive experience in regulatory strategy, management, and compliance.

Krisztina Turi Nemenyi, Ph.D, obtained their Ph.D in Chemical Engineering from the Technical University of Vienna in 1998, specializing in Environmental Chemistry. Krisztina also holds a Master's degree in Chemical Engineering with a specialization in Biochemistry, which they earned from the Technical University of Budapest in 1994. Recently, in 2021, they completed their Master of Business Administration (MBA) from the Massachusetts Institute of Technology.